Skip to main content

The information provided describes the symptoms of pelvic organ prolapse; a range of treatment options, as well as to do nothing; and, includes a list of questions that may be of assistance when you are speaking with your doctor about pelvic organ prolapse. The guidance also outlines the benefits and risks of the use of transvaginal mesh.

The statement includes recommendations to:

  • document date of birth and current body weight, basis for dose calculation (mg/kg) and dose in units of mass (mg) in all paediatric prescriptions
  • verify all dose calculations and the total dose
  • discuss the dose with parents and carers.

This PDF file of is not modifiable. The clinical and organisational aspects of the observation and response charts need to be customised for local use. The InDesign files are available on request so that  individual facilities can modify this chart for local use. Facilities will need to access to the InDesign software to make the required modifications to the charts.